Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age

Nabil F. Saba, George Blumenschein, Joel Guigay, Lisa Licitra, Jerome Fayette, Kevin J. Harrington, N. Kiyota, Maura L. Gillison, Robert L. Ferris, Vijayvel Jayaprakash, Li Li, P. Brossart

Research output: Contribution to journal › Article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab versus investigator's choice in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety in CheckMate 141 by age'. Together they form a unique fingerprint.

Medicine & Life Sciences